Soothing liver-qi stagnation method for cancer-related depression: A protocol for systematic review and meta-analysis
- PMID: 33120798
- PMCID: PMC7581120
- DOI: 10.1097/MD.0000000000022797
Soothing liver-qi stagnation method for cancer-related depression: A protocol for systematic review and meta-analysis
Abstract
Background: Cancer-related depression (CRD) is the most common mood disorder in patients with malignant tumors, negatively influencing the patient's daily life. Traditional Chinese medicine, as an alternative CRD therapy, has shown good treatment performance in recently years. Soothing liver-qi stagnation, as a classic therapy for depression, is based on traditional Chinese medicine theory. However, there is no evidence-based medical confirmation for the soothing liver-qi stagnation method for CRD treatment.
Methods: We will systematically search relevant articles from their inception to July 1, 2019 in the following electronic databases: the Cochrane Library, PubMed, EMBASE, Chinese National Knowledge Infrastructure Database, Chinese Biomedical Literature Database, Chinese Science and Technique Journals Database, and the Wan-fang Database. The primary outcome is the total scores of the Hamilton rating scale for depression and, the efficacy rate of reducing Hamilton rating scale for depression scores. The secondary outcomes are adverse reactions and quality of life as assessed by standard instruments. Two researchers will independently perform study selection, data extraction, and quality assessment. If there is any disagreement, it will be settled through third-party negotiations. We will assess the risk of bias and data synthesis using Review Manager (the Cochrane Collaboration) software, Version 5.3.0.
Results: This work will evaluate the clinical effectiveness and safety of the soothing liver-qi stagnation method for CRD.
Conclusion: This study may provide evidence-based medical corroboration for clinical application of the soothing liver-qi stagnation method for CRD treatment.
Prospero registration number: CRD42019145678.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
References
-
- Mehnert A, Brähler E, Faller H, et al. Four-week prevalence of mental disorders in patients with cancer across major tumor entities. J Clin Oncol 2014;32:3540–6. - PubMed
-
- Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev 2017;52:58–70. - PubMed
-
- Götze H, Friedrich M, Taubenheim S, et al. Depression and anxiety in long-term survivors 5 and 10 years after cancer diagnosis. Support Care Cancer 2020;28:211–20. - PubMed
-
- Ferrari M, Ripamonti CI, Hulbert-Williams NJ, et al. Relationships among unmet needs, depression, and anxiety in non-advanced cancer patients. Tumori 2019;105:144–50. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
